Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 483

1.

The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.

Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ.

Liver Transpl. 2008 Aug;14(8):1100-6. doi: 10.1002/lt.21398.

2.

Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.

Buchanan P, Dzebisashvili N, Lentine KL, Axelrod DA, Schnitzler MA, Salvalaggio PR.

Liver Transpl. 2009 Oct;15(10):1270-7. doi: 10.1002/lt.21802.

3.
4.

Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.

Ahmad J, Downey KK, Akoad M, Cacciarelli TV.

Liver Transpl. 2007 Nov;13(11):1564-9.

5.

MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation.

Santori G, Andorno E, Morelli N, Antonucci A, Bottino G, Mondello R, Castiglione AG, Valente R, Ravazzoni F, Di Domenico S, Valente U.

Transpl Int. 2005 Jan;18(1):65-72.

6.

Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?

Kanwal F, Hays RD, Kilbourne AM, Dulai GS, Gralnek IM.

Am J Gastroenterol. 2004 Sep;99(9):1726-32.

PMID:
15330910
7.

Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.

Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA Jr, Lobue A, Zurstrassen MP, Moraes JM Jr, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.

Transplant Proc. 2007 Oct;39(8):2511-3.

PMID:
17954160
8.

Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?

Cuomo O, Perrella A, Arenga G.

Transplant Proc. 2008 Jul-Aug;40(6):1906-9. doi: 10.1016/j.transproceed.2008.05.072.

PMID:
18675085
9.

The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation.

Kogure T, Ueno Y, Kawagishi N, Kanno N, Yamagiwa Y, Fukushima K, Satomi S, Shimosegawa T.

J Gastroenterol. 2006 Oct;41(10):1005-10. Epub 2006 Nov 9.

PMID:
17096070
10.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

11.

The economic impact of MELD on liver transplant centers.

Axelrod DA, Koffron AJ, Baker T, Al-Saden P, Dixler I, McNatt G, Sumner S, Vaci M, Abecassis M.

Am J Transplant. 2005 Sep;5(9):2297-301.

12.

[Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].

Sun J, Guo ZH, Lai TS, Tang YQ, Su L, Huo F, Wang SP, Pu MS, Wen Q.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(9):1731-2, 1742. Chinese.

PMID:
18819907
13.

Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD.

Liver Transpl. 2006 Jun;12(6):966-71.

14.

Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.

Ishigami M, Honda T, Okumura A, Ishikawa T, Kobayashi M, Katano Y, Fujimoto Y, Kiuchi T, Goto H.

J Gastroenterol. 2008;43(5):363-8. doi: 10.1007/s00535-008-2168-7. Epub 2008 Jul 1.

PMID:
18592154
15.

Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.

Cholongitas E, Marelli L, Kerry A, Goodier DW, Nair D, Thomas M, Patch D, Burroughs AK.

Am J Transplant. 2007 Mar;7(3):685-92. Epub 2007 Jan 11.

16.

Liver transplantation organ allocation between Child and MELD.

Graziadei I.

Wien Med Wochenschr. 2006 Jul;156(13-14):410-5. Review.

PMID:
16937044
17.

Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.

Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.

Eur J Clin Invest. 2009 Jan;39(1):65-71. doi: 10.1111/j.1365-2362.2008.02063.x.

PMID:
19087131
18.

Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation.

Machicao VI, Srinivas TR, Hemming AW, Soldevila-Pico C, Firpi RJ, Reed AI, Morelli GJ, Nelson DR, Abdelmalek MF.

Liver Transpl. 2006 May;12(5):754-61.

19.

A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation.

Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, Weinstein JS, Murray NG, Goldstein RM, Klintmalm GB.

Liver Transpl. 2003 Feb;9(2):117-23.

20.

Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.

Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U.

Transplant Proc. 2008 Jul-Aug;40(6):1903-5. doi: 10.1016/j.transproceed.2008.05.016.

PMID:
18675084

Supplemental Content

Support Center